Glaxo Wellcome Research and Development S.A. other research news

Researchers reported the isolation of a chemokine blocker from the herpesvirus that is suspected as the causative agent in KS. The blocker is broadly active, binding to many chemokine receptors and preventing infection by many strains of HIV. It blocks calcium mobilization induced by chemokines. ...